Impact of comorbidities in the response of atopic patients treated with dupilumab: a real‐life study up to 36 weeks. (26th July 2022) - Mastorino, L.; Cantafio Duò, V.L.; Vecco, C.; Gelato, F.; Giordano, S.; Roccuzzo, G.; Cavaliere, G.; Avallone, G.; Ortoncelli, M.; Ribero, S.; Quaglino, P.